These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 12778856

  • 1. [Role of diet in the management of osteodystrophy during progressive renal insufficiency].
    Martínez I, Saracho R, Ocharán J, Muñoz RI, Montenegro J.
    Nefrologia; 2003; 23 Suppl 2():57-63. PubMed ID: 12778856
    [Abstract] [Full Text] [Related]

  • 2. [Clinical evidence and treatment for optimum concentration of parathyroid hormone, calcium and phosphate in chronic renal failure].
    Hoshino J, Ubara Y, Takaichi K.
    Clin Calcium; 2004 May; 14(5):731-7. PubMed ID: 15577034
    [Abstract] [Full Text] [Related]

  • 3. The interaction of PTH and dietary phosphorus and calcium on serum calcitriol levels in the rat with experimental renal failure.
    Martin-Malo A, Rodriguez M, Martinez ME, Torres A, Felsenfeld AJ.
    Nephrol Dial Transplant; 1996 Aug; 11(8):1553-8. PubMed ID: 8856210
    [Abstract] [Full Text] [Related]

  • 4. [Early treatment of secondary hyperparathyroidism in moderate renal insufficiency: low-phosphorus diet versus calcium carbonate].
    Aresté N, Amor J, Cambil T, Salgueira M, Sánchez-Palencia R, Páez C, Gómez O, Palma A.
    Nefrologia; 2003 Aug; 23 Suppl 2():64-8. PubMed ID: 12778857
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prevention of enhanced parathyroid hormone secretion, synthesis and hyperplasia by mild dietary phosphorus restriction in early chronic renal failure in rats: possible direct role of phosphorus.
    Yi H, Fukagawa M, Yamato H, Kumagai M, Watanabe T, Kurokawa K.
    Nephron; 1995 Aug; 70(2):242-8. PubMed ID: 7566311
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prevention of metabolic bone disease in the pre-end-stage renal disease setting.
    Coburn JW, Elangovan L.
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S71-7. PubMed ID: 11443772
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Dec; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Prevention and treatment of renal osteodystrophy: present and future].
    Fernández E, Craver L.
    Nefrologia; 2006 Dec; 26 Suppl 3():19-27. PubMed ID: 17469423
    [No Abstract] [Full Text] [Related]

  • 13. Pathogenesis of bone and mineral related disorders in chronic kidney disease: key role of hyperphosphatemia.
    Román-García P, Carrillo-López N, Cannata-Andía JB.
    J Ren Care; 2009 Mar; 35 Suppl 1():34-8. PubMed ID: 19222729
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of the effects of daily and intermittent-dose calcitriol on serum parathyroid hormone and ionized calcium concentrations in normal cats and cats with chronic renal failure.
    Hostutler RA, DiBartola SP, Chew DJ, Nagode LA, Schenck PA, Rajala-Schultz PJ, Drost WT.
    J Vet Intern Med; 2006 Mar; 20(6):1307-13. PubMed ID: 17186842
    [Abstract] [Full Text] [Related]

  • 17. [K/DOQI clinical practice guidelines for management of renal osteodystrophy in predialysis patients].
    Okada N, Tsubakihara Y.
    Clin Calcium; 2004 May; 14(5):698-706. PubMed ID: 15577030
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.